Severe anemia caused by hereditary hemorrhagic telangiectasia in a patient with Sjogren's syndrome and primary biliary cirrhosis

被引：1
|
作者：
Qin, Yao [1 ]
Yin, Geng [2 ]
Xie, Qi-Bing [2 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Rheumatol & Immunol, Chengdu 610041, Sichuan, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2019年 / 132卷 / 19期
关键词：
D O I：
10.1097/CM9.0000000000000434
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：2382 / 2383
页数：2
相关论文
共 50 条
  • [21] Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome
    Anantharaju, A
    Baluch, M
    Van Thiel, DH
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (04) : 830 - 833
  • [22] Non-Hodgkin's lymphoma & primary biliary cirrhosis with Sjogren's syndrome
    Hahn, JS
    Kim, C
    Min, YH
    Ko, YW
    Suh, CO
    Park, YY
    YONSEI MEDICAL JOURNAL, 2001, 42 (02) : 258 - 263
  • [23] Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia
    Philip Fodstad
    Sinan Dheyauldeen
    Marit Rinde
    Gregor Bachmann-Harildstad
    Annals of Hematology, 2011, 90 : 611 - 612
  • [24] THALIMODID USAGE IN SEVERE RECURRENT EPISTAXIS IN HEREDITARY HEMORRHAGIC TELANGIECTASIA PATIENT
    Ozgur, G.
    Ugur, B.
    Yildirim, M.
    Sayin, S.
    Ayli, M.
    LEUKEMIA RESEARCH, 2017, 61 : S42 - S42
  • [25] Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia
    Fodstad, Philip
    Dheyauldeen, Sinan
    Rinde, Marit
    Bachmann-Harildstad, Gregor
    ANNALS OF HEMATOLOGY, 2011, 90 (05) : 611 - 612
  • [26] Iron deficiency anemia in a patient with hereditary hemorrhagic telangiectasia. Case report
    Mozdon, Maria A.
    Ponomarev, Rodion, V
    Tsvetaeva, Nina, V
    Shabrin, Aleksey, V
    Ermachenkova, Evgeniya I.
    Larichev, Sergei E.
    Lukina, Elena A.
    Ponomarev, Rodion V.
    Tsvetaeva, Nina V.
    Shabrin, Aleksey V.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (07): : 580 - 585
  • [27] Association of Sjogren syndrome, autoimmune thyroiditis, sarcoidosis, primary biliary cirrhosis and primary amyloidosis in a single patient
    Fuertes, I.
    Espinosa, G.
    Ramos-Casals, M.
    Cervera, R.
    REVISTA CLINICA ESPANOLA, 2007, 207 (07): : 376 - 376
  • [28] Successful treatment of primary Sjogren's syndrome complicated with primary biliary cirrhosis and lung involvement
    Altinbas, Akif
    Arik, Gunes
    Kalyoncu, Umut
    Akdogan, Ali
    Karadag, Omer
    Kisacik, Bunyamin
    Ertenli, A. Ihsan
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2010, 21 (01): : 60 - 62
  • [29] Autoimmune hemolytic anemia in an elderly patient with primary Sjogren's syndrome
    Kikawada, M
    Watanabe, D
    Kimura, A
    Hanyu, H
    Serizawa, H
    Iwamoto, T
    INTERNAL MEDICINE, 2005, 44 (12) : 1312 - 1315
  • [30] Bevacizumab for treating Hereditary Hemorrhagic Telangiectasia patients with severe hepatic involvement or refractory anemia
    Vazquez, Carolina
    Laura Gonzalez, Maria
    Ferraris, Augusto
    Carlos Bandi, Juan
    Martin Serra, Marcelo
    PLOS ONE, 2020, 15 (02):
12345